• A COP21 Executive Briefing and Roundtable for Business with USCIB

    December 05 2015, 09:30 - 14:00
    Location: George C. Marshall Center, Paris

    A COP21 Executive Briefing and Roundtable for US Business


    A Vision of US Business Engagement: Informing and Implementing the Paris Outcomes

    This is a free event, by invitation for AmCham members only. 



    9:30 am


    Registration and Breakfast


    10:00 – 10:20 am





    10:20 – 10:50 am

    Welcome remarks:

    • ·         Peter Robinson, President & CEO, USCIB
    • ·         Pierre Dejoux, President, Otis Europe


    Paris Outcomes – Expectations and Business Issues: Nick Campbell, Arkema

    • ·         Business Issues in the negotiations
    • ·         Key government positions
    • ·         Expected outcomes and more work to do



    11:00 – 12:00 pm



    Looking Ahead

    • ·         Status of National Actions and the Challenge Ahead – Dr. Henry D. Jacoby, Sloan School of Management, MIT
    • ·         Technology innovation and deployment opportunities – Vincent Champain, General Electric
    • ·         UNFCCC work plan in 2016 – Where does business engage? – Norine Kennedy, USCIB


    12:00 – 1:00 pm






    1:00 – 2:00pm





















    Mr Dan Utech, Deputy Assistant to the President for Energy and Climate Change

    High Level Roundtable, moderated by
    Peter Robinson, President and CEO, USCIB and Pierre Dejoux, President, Otis Europe and
    President, Intelligent Building Technologies & Operations Europe, United Technologies


    A Vision of Business Engagement : Informing and Implementing the Paris Outcomes


    • ·         Mr. John Danilovich, Secretary General, International Chamber of Commerce
    • ·         Dr. Neil C. Hawkins, Corporate Vice President of Sustainability for The Dow Chemical Company
    • ·         Mr. James Mahoney, Global Corporate Communications and Public Policy Executive, Bank of America
    • ·         Dr. Claus Stig Pedersen, Senior Director& Head of Corporate Sustainability Novozymes